ABSTRACT
Neuropathic Pain ................................................................................ 89 6.4.3 Prodynorphin Mutations as the Etiological Basis
of Spinocerebellar Ataxia Type 23 .....................................................90 6.4.4 Putative Role for the Dynorphin-κ-Opioid Receptor System in
Oligodendrocyte Function and Dymyelinating Disease ..................... 91 6.4.5 Dynorphin-κ-Opioid System in the Pathogenesis of Neuro-
Acquired Immunodeciency Syndrome .............................................92 6.5 Conclusions .....................................................................................................93 Acknowledgments ....................................................................................................93 References ................................................................................................................93
